Treatment for acute bronchiolitis before and after implementation of new national guidelines: a retrospective observational study from primary and secondary care in Oslo, Norway.

BMJ Paediatrics Open
Nicolai KlemOdd Martin Vallersnes

Abstract

Acute bronchiolitis treatment guidelines changed in Norway in 2013, no longer recommending the use of nebulised epinephrine. We aimed to assess whether these changes were successfully implemented in both primary and secondary care. Secondary aims were to compare the difference in management of acute bronchiolitis patients in primary and secondary care between 2009 and 2017. We retrospectively registered data on demographics, clinical features and management from electronic medical records of all infants (<12 months of age) diagnosed with acute bronchiolitis at a primary care centre (Oslo Accident and Emergency Outpatient Clinic) and a secondary care centre (Oslo University Hospital) in Norway in 2009, 2014 and 2017. All patient records were individually reviewed to ensure data accuracy. We included 680 (36.3%) patients from primary care and 1195 (63.7%) from secondary care. There was a reduction in the use of nebulised epinephrine from 2009 to 2017 from 66.9% to 16.1% of cases (p<0.001) in primary care and from 59.1% to 4.9% (p<0.001) in secondary care. In parallel, there was an increase in the use of nebulised saline treatment, from 0.8% to 53.8% (p<0.001) in primary care and from 39.3% to 65.3% (p<0.001) in secondary care. Th...Continue Reading

References

Nov 1, 1984·Archives of Disease in Childhood·B FriisP Uldall
Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Nov 26, 2009·The Pediatric Infectious Disease Journal·Dan MironImad Kassis
Jan 27, 2010·Pediatrics·Joseph J Zorc, Caroline Breese Hall
Jun 14, 2013·The New England Journal of Medicine·Håvard Ove SkjervenKarin C Lødrup Carlsen
Apr 4, 2014·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Knut ØymarIngvild Bruun Mikalsen
Jun 24, 2014·Journal of Evaluation in Clinical Practice·Marjolein LugtenbergGert P Westert
Aug 15, 2014·The American Journal of the Medical Sciences·Raja Ahsan AftabKashifUllah Khan
Oct 29, 2014·Pediatrics·Shawn L RalstonSinsi Hernandez-Cancio
Oct 29, 2015·The Journal of Infectious Diseases·Håvard O SkjervenUNKNOWN ORAACLE Study Group
Jan 7, 2016·The New England Journal of Medicine·H Cody Meissner
Jul 28, 2016·BMC Family Practice·Bjarne AustadAnne-Sofie Helvik
Mar 22, 2018·The New England Journal of Medicine·Donna FranklinAndreas Schibler
Mar 25, 2018·Emergency Medicine Australasia : EMA·Ed OakleyUNKNOWN Paediatric Research in Emergency Departments International Collaborative (PREDICT)
May 17, 2018·European Journal of Pediatrics·Minna MecklinMatti Korppi
Jan 19, 2019·Journal of the Pediatric Infectious Diseases Society·Jesse PapenburgBrett Burstein
Nov 2, 2019·Archives of Disease in Childhood·Marta MontejoJavier Benito
Jul 15, 2020·Pediatrics·Amy ZipurskyUNKNOWN PEDIATRIC EMERGENCY RESEARCH NETWORKS (PERN)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.